Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases

TG-MVA builds on Transgene’s expertise in MVA (Modified Vaccinia Ankara) viral vectors, which are well established in smallpox vaccines ...
Business Wire

Transgene provides business update and Q1 2023 financial position

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...
Business Wire

Transgene to Present Data on its Two Therapeutic Cancer Vaccines at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced ...
Finanznachrichten

Transgene S.A.: Transgene Provides Business and Financial Update for Q1 2026

Enrolment completed in Phase 2 part of head and neck cancer clinical trial (TG4050) - Topline data expected by the end of Q1 2028 as per plan Phase 1 data from TG4050 in head and neck cancer published ...
Seeking Alpha

Transgene SA (TRGNF) Discusses TG4050 Phase I Immunological Data in Head and Neck Cancer from SITC Presentation Transcript

Good morning, and welcome to the Transgene conference call. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Transgene website following ...
Nasdaq

Transgene and BioInvent - First Patient Treated in Part B of Phase I Trial Assessing the Novel Oncolytic Virus BT-001 in Combination With KEYTRUDA® (pembrolizumab)

STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)-- Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and ...

Transgene’s Combined General Meeting of May 22, 2026

Strasbourg, France, May 22, 2026, 5:45 p.m. CET – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 22, 2026) at 11:00 a.m. CET at the Company’s ...